Twenty-four shortlisted projects from the first stage of UKRI’s Strength in Places Fund have been awarded up to £50,000 funding to allow the development of full-stage bids. Four to eight of the strongest teams will receive between £10m and £50m each. Read more
Tag Archives: Leeds
2nd UK Workshop on Membrane Proteins: Solubilisation and Biophysical Characterisation
University of Leeds | 3 – 5 April 2019
CBMNet are sponsoring this Biochemical Society Training Event, a follow up to the successful workshop “Experimental Techniques for Studying Proteins and Lipids in Biological Membranes” held at Aston University in July – August 2018 (read the event report here). Read more
From January 1st 2016, we are pleased to announce the the following will be joining our management board:
- Dr Sam Miller (University of Aberdeen)
Sam is currently a lecturer in the School of Medical Sciences. Her research career is focussed on structure and function relationships in two sets of ion channels in Escherichia coli involved in bacterial survival of changes in their environments.
- Dr Lars Jeuken (University of Leeds)
Lars is a Reader in Biophysics in the Faculty of Biological Sciences. He researches redox-active membrane proteins and biological electron transfer, with the aim of controlling the interaction between biological macromolecules and inorganic ‘solid’ surfaces.
- Ian Hodgson (FujiFilm Diosynth Biotechnologies)
Ian is the Head of Molecular Biology, R & D at FujiFilm Diosynth Biotechnologies, based in Billingham. He has over 26 years of experience in molecular biology and in particular the design, construction and testing of protein expression vectors for biopharmaceutical production (eukaryotic and prokaryotic).
- Dr Doug Cossar (Croda Europe Ltd)
Doug took up his present position at Croda Europe Ltd, to manage the Biotechnology Research Group in Widnes. His role is to develop route to manufacture for biotechnology-derived speciality chemicals for delivery across an array of market sectors, from Health Care (eg excipients for drug formulation or speciality lipids) to the Oil Field (surface-active materials).
The CBMNet Management Board oversees the strategic goals of the network; delivery and dissemination of innovative approaches relevant to remit; promotion of academic-industrial interactions; processes for inviting, assessing and allocating Proof-of-Concept funding; reviewing strategic goals and network events.